Our mission is 4-fold:
- To carry out internationally competitive basic and translational research into human stem cell biology
- To maintain state-of-the-art technological platforms for the production, characterization and differentiation of human pluripotent stem cells
- To facilitate the use of human stem cells in clinical experiments and trials
- To provide expertise and knowledge about human stem cell biology, technology and use to Norwegian researchers and clinicians, patients and their support groups, and health and government policy makers
Contact information for general requests:
Phone: +47 22851578
Inquiries from the media should be made to Hege Brincker Fjerdingstad by email or telephone.
All patient inquiries should be made by email to Hege Brincker Fjerdingstad. The Center can not administer patient inquiries made through any other channels.
The Norwegian Center for Stem Cell Research was established in 2009 at the Oslo University Hospital-National Hospital (Rikshospitalet) through a directive from the Norwegian Ministry of Health, with funding administered by the Norwegian Research Council.
The Centers principal objectives is to increase the pace of existing stem cell research in Norway, establish a platform for human pluripotent stem cell research, and build translational bridges that facilitate the clinical use of stem cells to treat patients.
In addition to being a driving force for Norwegian stem cell research, the Center is to play a national role in training researchers, disseminating knowledge about stem cells to researchers, clinicians, and the general public, and increasing collaboration between Norwegian and international stem cell research communities.
Housed in facilities located at Domus Medica, Institute of Basic Medical Sciences, within the Department of Biochemistry, the Center contains several individual research laboratories and a core facility for the production and characterization of stem cells.The Center is headed by Director Joel C. Glover, Professor at the Department of Physiology, University of Oslo, and Vice-director Philippe Collas, Professor at the Department of Biochemistry, University of Oslo.
International Advisory Board:
Professor Anthony Atala, Wake Forest University School of Medicine
Professor Outi Hovatta, Karolinska Institutt
Professor Ian Duncan, University of Wisconsin Madison
Professor Catherine Verfaillie, Katholieke Universiteit Leuven
Professor Ariel Ruiz i Altaba, University of Geneva Medical School